Trellus Management Company’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Trellus Management Company’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-112,500	Closed	-$251K	–	90
2017 Q4	$251K	Sell	112,500 -250,000	-69%	-$621K	0.34%	57
2017 Q3	$1.05M	Buy	362,500 +17,500	+5%	+$59.7K	1.44%	18
2017 Q2	$1.53M	Buy	345,000 +145,000	+73%	+$598K	2.26%	12
2017 Q1	$932K	Buy	200,000 +99,136	+98%	+$575K	1.41%	23
2016 Q4	$614K	Sell	100,864 -62,036	-38%	-$324K	0.9%	34
2016 Q3	$898K	Hold	162,900	–	–	1.3%	18
2016 Q2	$619K	Hold	162,900	–	–	1.01%	32
2016 Q1	$450K	Hold	162,900	–	–	0.78%	33
2015 Q4	$924K	Hold	162,900	–	–	1.36%	20
2015 Q3	$863K	Hold	162,900	–	–	1.27%	19
2015 Q2	$1.35M	Sell	162,900 -37,900	-19%	-$184K	1.53%	17
2015 Q1	$928K	Buy	200,800 +45,000	+29%	+$146K	1.1%	25
2014 Q4	$475K	Hold	155,800	–	–	0.7%	45
2014 Q3	$434K	Hold	155,800	–	–	0.37%	67
2014 Q2	$634K	Hold	155,800	–	–	0.53%	55
2014 Q1	$827K	Sell	155,800 -2,181	-1%	-$12.2K	0.74%	32
2013 Q4	$877K	Hold	157,981	–	–	1.06%	26
2013 Q3	$712K	Hold	157,981	–	–	0.9%	38
2013 Q2	$673K	Buy	+157,981	New	+$794K	0.85%	40

Other funds holding SGYP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Trellus Management Company's SGYP Position: Q1 2018 in Review

Trellus Management Company sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2018, closing a stake of 112,500 shares — an estimated $251K sold.

Trellus Management Company first reported a position in SGYP in Q2 2013 and held it in 19 quarters. The position peaked at $1.53M in Q2 2017. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.

Trellus Management Company reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2018 after selling out during the quarter.
Trellus Management Company sold 112,500 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2018, an estimated $251K.
Trellus Management Company first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 19 quarters.
Trellus Management Company's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.53M in Q2 2017.
147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2018.

Based on Trellus Management Company's 13F filing for Q1 2018, filed 2 May 2018.